PCR Molecular Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Global Top Polymerase Chain Reaction (PCR) Molecular Diagnostics Companies and it is segmented by Product Type (Instrument, Reagents and Consumables and Software) Application (Infectious Disease Testing, Oncology Testing, Other Applications), End Users (Hospitals, Diagnostics Laboratories, Others) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market size and forecast values are provided in terms of (USD) for all the above segments.

PCR Molecular Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

PCR Molecular Diagnostics Industry Overview

The PCR Molecular Diagnostics market is moderately competitive with several players across the globe. In terms of market share, few of the major players currently dominate the market. With the rising patient awareness levels and high prevalence of infectious and cancer diseases, especially the COVID 19, many regional players are expected to grow their presence in the market. Some of the major players of the market are Abbott Laboratories, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Takara Bio, Inc., Qiagen N.V, etc

PCR Molecular Diagnostics Market Leaders

  1. Abbott Laboratories

  2. Thermo Fisher Scientific

  3. Bio-Rad Laboratories, Inc

  4. Takara Bio, Inc

  5. Qiagen N.V.

  6. *Disclaimer: Major Players sorted in no particular order
Market Concentration_PCR Molecular Diagnostics Market.png